Total Payments
$1,359
2019 Payments
$41.44
Companies
10
Transactions
25
Payment Breakdown by Category
Food & Beverage$1,359 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,359 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $249.94 | 2 | $0 (2017) |
| Novo Nordisk Inc | $239.88 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $239.84 | 3 | $0 (2017) |
| Mannkind Corporation | $223.43 | 9 | $0 (2019) |
| Horizon Pharma plc | $120.03 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $100.34 | 1 | $0 (2017) |
| Gilead Sciences Inc | $100.00 | 1 | $0 (2017) |
| AbbVie, Inc. | $58.53 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.03 | 1 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $12.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $41.44 | 3 | Mannkind Corporation ($27.41) |
| 2018 | $78.39 | 6 | MannKind Corporation ($65.14) |
| 2017 | $1,239 | 16 | SANOFI-AVENTIS U.S. LLC ($249.94) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/15/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/15/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/04/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/09/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/12/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/14/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/17/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/09/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Endocrinology | ||||||
| 12/07/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $45.28 | General |
| Category: Virology | ||||||
| 11/07/2017 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/14/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: DIABETES | ||||||
| 08/10/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $100.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2017 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $108.31 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/12/2017 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $120.03 | General |
| Category: NONE | ||||||
| 06/21/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HCV | ||||||
| 04/13/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $95.12 | General |
| Category: Diabetes | ||||||
| 04/10/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Diabetes | ||||||
| 03/23/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 03/02/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $100.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.14 | General |
| 02/16/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/15/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $110.85 | General |
| Category: Diabetes | ||||||
| 02/03/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Gout/Rheumatology | ||||||
| 01/18/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $49.34 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. Mario Mancheno, M.D
Dr. Mario Mancheno, M.D is a Surgery healthcare provider based in Hoboken, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417041013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Mancheno, M.D has received a total of $1,359 in payments from pharmaceutical and medical device companies, with $41.44 received in 2019. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,359).
Ad
Practice Information
- Specialty Surgery
- Location Hoboken, NJ
- Active Since 10/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417041013
Products in Payments
- AFREZZA (Drug) $223.43
- Tresiba (Drug) $205.97
- TOUJEO (Drug) $125.00
- SOLIQUA (Drug) $124.94
- NO_PRODUCT (Drug) $120.03
- BELSOMRA (Drug) $100.50
- XIFAXAN (Drug) $100.34
- Epclusa (Drug) $100.00
- ZEPATIER (Drug) $90.00
- JANUVIA (Drug) $49.34
- Mavyret (Drug) $45.28
- Victoza (Drug) $19.77
- TRULANCE (Drug) $14.03
- Creon (Drug) $13.25
- Uloric (Drug) $12.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.